Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Strata Oncology Secures $26 Million in Funding

Posted in Healthcare Services Investing

Strata Oncology has announced it has secured $26 million in series B funding.

Strata, based in Ann Arbor, Mich., describes itself as a precision oncology platform company.

New investors in the company were Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management and Renaissance Venture Capital Fund. They joined existing investors Arboretum Ventures and Baird Capital.

Strata indicated it intends to use the latest round of funding for multiple purposes, including expanding its client base and further developing solutions.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree